Arthritis & Rheumatology

Article	Citations
No differences in myocardial perfusion between treatment‐naive, early rheumatoid arthritis patients and healthy controls	878
	334
Higher alcohol consumption was associated with greater incidence of total hip replacement due to hip osteoarthritis in a dose‐dependent manner in women: comment on the article by Marchand et al	215
The Evolving Role of the Rheumatology Practitioner in the Care of Immunocompromised Patients in the COVID‐19 Era	176
Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis	163
Possible confounding factors explaining data on heart failure risk in patients with polymyositis/dermatomyositis: comment on the article by Lin et al	162
	154
In This Issue	150
Clinical Connections	141
Association of change in metabolic syndrome status with altered risk of incident gout: comment on the article by Eun et al	138
Clinical Connections	120
Systemic lupus erythematosus and atherosclerosis progression risk: comment on the article by Papazoglou et al.	116
Seronegative palindromic rheumatism: what are we talking about? Comment on the article by Yang et al	113
Using Mice to Model Human Osteoarthritis: Age, Biologic Sex, and Pain Matter	113
Clinical Images: Rice bodies in pseudogout	99
Reply	97
In This Issue	95
The Devil Is in the Detail: Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty	92
Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis	88
National Mortality Databases to Assess Disease Burden in Systemic Autoimmune Diseases: A Valuable Resource, But with Limitations	85
Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool (PRESTO): A Step Towards Prevention	83
Exposure to occupational inhalants and the risk of developing rheumatoid arthritis: A systematic review and meta‐analysis	78
Pregnancy Outcomes in Women With Psoriatic Arthritis in Relation to Presence and Timing of Antirheumatic Treatment	73
CCL19‐Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase	73
A methodologic problem and a conceptual issue related to the new 2022 antineutrophil cytoplasmic antibody–related vasculitis criteria sets: comment on criteria sets approved by the American College of	69

COVID‐19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settings	64
Correction to “Novel Genetic Loci in Early‐Onset Gout Derived From Whole‐Genome Sequencing of an Adolescent Gout Cohort”	64
Minimal tofacitinib dose for maintenance in axial spondyloarthritis: real‐world data from a resource‐limited setting	64
Gut Microbiome and Osteoarthritis: Insights From the Naturally Occurring Canine Model of Osteoarthritis	64
Endogenous Retroelement Activation is Implicated in Interferon‐α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis	63
At the Heart of Treating Kawasaki Disease: The Search for New Approaches to Prevent Coronary Artery Aneurysms	62
Interleukin‐13 Receptor α1–Mediated Signaling Regulates Age‐Associated/Autoimmune B Cell Expansion and Lupus Pathogenesis	61
Distinct natural killer cell signature in still's disease: Insights from a multinational immunome project consortium for autoinflammatory disorders	61
The impact of non‐steroidal anti‐inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: 10‐year results from an inception cohort	59
Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis	57
Contribution of Interleukin‐4–Induced Epithelial Cell Senescence to Glandular Fibrosis in IgG4‐Related Sialadenitis	56
NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2‐Mediated Pyroptosis Through the Phosphorylated Salt‐Inducible Kinase 1/Sterol Regulatory Element Binding T	55
Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin‐2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus	53
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial	53
Identification of Shared and Asian‐Specific Loci for Systemic Lupus Erythematosus and Evidence for Roles of Type III Interferon Signaling and Lysosomal Function in the Disease: A	52
Clinical Connections	52
Reply	52
Knee Alignment Correction by High Tibial Osteotomy Reduces Symptoms and Synovial Inflammation in Knee Osteoarthritis Accompanied by Macrophage Phenotypic Change From M1 to M2	51
A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis	51
Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population‐Based Study Over Four Decades Using the Lupus Midwest Network	51
Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthr	51
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases	50
Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy	50
Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide	49
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Tr	49
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria	49
Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis	48
Alteration of Gut Microbiota in Individuals at High‐Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immu	48
Immediate Open Access: The Good, the Bad, and the Impact on Academic Society Publishing	48
Winner of the 2021 American College of Rheumatology Annual Image Competition	46
Reply	46
	45
Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits	44
Effects of Secukinumab on Enthesiophyte and Erosion Progression in Psoriatic Arthritis: A One‐Year Double‐Blind, Randomized, Placebo‐Controlled Trial Using High‐Resolution Peripheral Quantitative Comp	43
Journal Club	43
Issue Information	42
Vertebral Bone Mineral Density, Vertebral Strength, and Syndesmophyte Growth in Ankylosing Spondylitis: The Importance of Bridging	42
In This Issue	42
Clinical Image: Nasal rim sign: A clinical manifestation of dermatomyositis	41
Journal Club	41
Journal Club	40
Clinical Connections	40
Development and External Validation of a Model Predicting New‐Onset Chronic Uveitis at Different Disease Durations in Juvenile Idiopathic Arthritis	40
Not Only Excruciating Pain: Might a Gout Flare Episode Lead to Pulmonary Embolism?	40
Reply	39
Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis–Associated Lymphoproliferative Disorders	39
Role of autoantibodies in lupus nephritis: comment on the article by Fava et al	39
	39
Reply	39
	39

	38
Reply	38
Reply	38
Revisiting the Synovium as a Structural Correlate of Pain in Osteoarthritis	38
Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation: An Early Remission Induction Study	37
Comment on: Comparative Cardiovascular Safety of NSAID versus Colchicine Use When Initiating Urate‐Lowering Therapy Among Patients with Gout: Target Trial Emulations	37
Oxidative Stress by the Mitochondrial Monoamine Oxidase B Mediates Calcium Pyrophosphate Crystal–Induced Arthritis	37
Longitudinal Analysis of Somatic Mosaicism and Clonal Hematopoiesis in Cryopyrin‐Associated Periodic Syndrome	36
Using Two Predictive Models to Capture Two Types of Poor Outcomes in Knee Arthroplasty: A Multisite Longitudinal Cohort Study	36
Reply to Redlining, Structural Racism, and Psoriatic Arthritis Outcomes	36
Critical Role of Notch‐1 in Mechanistic Target of Rapamycin Hyperactivity and Vascular Inflammation in Patients With Takayasu Arteritis	36
Abstract Supplement ACR Convergence 2025	36
Reply to the Letter to the Editor	35
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb<	35
Effects of Anti–Tumor Necrosis Factor Therapy on Osteoblastic Activity at Sites of Inflammatory and Structural Lesions in Radiographic Axial Spondyloarthritis: A Prospective Proof‐of‐Concept	35
Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling	35
Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib	35
Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis	34
Lysosome‐Associated Membrane Protein 3 Induces Lysosome‐Dependent Cell Death by Impairing Autophagic Caspase 8 Degradation in the Salivary Glands of Individuals With Sjögren's Di	34
Superiority of Low‐Dose Benzbromarone to Low‐Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion	34
Variability of Primary Sjögren's Syndrome Is Driven by Interferon‐α and Interferon‐α Blood Levels Are Associated With the Class II HLA–DQ Locus	33
No Added Value of Duloxetine in Patients With Chronic Pain due to Hip or Knee Osteoarthritis: A Cluster‐Randomized Trial	33
The 2024 Vasculitis Foundation Quality Care Summit: Seeking Strategies to Improve Care for All Patients	33
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome	33
Reply	33
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus	32
Global burden of osteoarthritis attributable to high body mass index, 1990 to 2021: insights from the Global Burden of Disease study 2021: comment on the article by Lu et al	32
Serum Urate–Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Trial	32
Mucosal‐Associated Invariant T Cells in Rheumatic Diseases	32
Trends in New Use of Disease‐Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022	32
EAT‐Lancet Diet Modifies the Risk of Rheumatoid Arthritis Through Metabolomic Signature	32
Choosing to End African American Health Disparities in Patients With Systemic Lupus Erythematosus	31
Reply	31
Clinical Images: Increased bone metabolism in secondary hyperparathyroidism	30
Issue Information ‐ General Info	30
Reply	30
Reply	30
Corrigendum	30
Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups	30
The genetic contribution of inflammation to the increased risk of cardiovascular disease in rheumatoid arthritis: comment on the article by Yuan et al	30
Journal Club	30
Clinical Connections	30
Clinical Images: Burton line and scar hyperpigmentation in a patient with severe lead poisoning and saturnine gout	30
Reply	30
Doctor versus artificial intelligence: patient and physician evaluation of large language model responses to rheumatology patient questions: comment on the article by Ye et al	29
In This Issue	29
An investigation of the relationship between weight management and gout: insights from the THIN database study and recommendations for improvement. Comment on the article by Wei et al	29
Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel	29
Reply	29
In This Issue	29
Hydroxychloroquine dose after hospitalization for systemic lupus erythematosus: comment on the article by Nestor et al	29
	29
Changes in Descending Pain Modulation During Anti–Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and Spondyloarthritis	28
The Efficacy of Short‐Term Bridging Strategies With High‐ and Low‐Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double‐Blin	28
In This Issue	28
Heightened Proinflammatory Glycosylation of Borrelia burgdorferi IgG Antibodies in Synovial Fluid in Patients With Antibiotic‐Refractory Lyme Arthritis	28
Effect of time to start of biologic therapy on treatment response in childhood arthritis: Results from the UCAN CAN‐DU study	28
Clinical Images: Transient perivascular inflammation of the carotid artery syndrome	28
EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis	28
Artificial Intelligence and Deep Learning for Rheumatologists	28
Clinical images: VEXAS syndrome presenting as treatment‐refractory polyarteritis nodosa	28
Biopsy‐Proven Hydroxychloroquine‐Induced Cardiomyopathy in an Adolescent With Systemic Lupus Erythematosus	28
A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis	28
A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease	28
ZBTB20 Regulating Postnatal Articular Cartilage Development and Homeostasis: Implications for Early‐Onset Osteoarthritis	27
Programmed Death Ligand 1–Expressing Macrophages and Their Protective Role in the Joint During Arthritis	27
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis	27
Role of Human Mesenchymal Stem Cells and Derived Extracellular Vesicles in Reducing Sensory Neuron Hyperexcitability and Pain Behaviors in Murine Osteoarthritis	27
Screening of Environmental Chemicals to Characterize Exposures in Participants With Systemic Lupus Erythematosus	27
DNA methylation profiling reveals distinct epigenetic clusters and suggests epigenetic patterns associated with sex and disease activity in childhood‐onset lupus	27
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis	26
The oral microbiota in persons at risk for rheumatoid arthritis: follow‐up data for the article by Kroese et al	26
Associations and Diagnostic Accuracy of Ultrasound Features in Knee Osteoarthritis: Cross‐sectional Results from a Large Community‐based Cohort: comment on the article by Yates KA et al.	26
Reply	26
Concordance between ultrasound and physical examination in enthesitis assessment: a call for further investigation: comment on the article by Di Matteo et al	26
Systemic autoimmune rheumatic disease risk is associated with long‐term exposure to fine particulate matter: comment on the article by Geslin et al	26
Clinical images: Huriez syndrome, a rare scleroderma mimic	26
The Transition From Residency to Fellowship: Enhancing Training by Increasing Transparency	26
Do We Need More Exercise and Osteoarthritis Randomized Clinical Trials?	26
Retraction	25

	25
Addressing readability of online patient materials: comment on the American College of Rheumatology online information pages for patients and caregivers	25
Issue Information	25
Journal Club	25
Local Ancestry at the Major Histocompatibility Complex Region is Not a Major Contributor to Disease Heterogeneity in a Multiethnic Lupus Cohort	25
Strength Training is Associated With Less Knee Osteoarthritis: Data From the Osteoarthritis Initiative: Comment on the Article by Lo et al	25
Reply	25
Journal Club	24
Erratum	24
Immunological Profiling suggests an Association between Treg dysfunction and Pain in Knee Osteoarthritis	24
Should lipoprotein(a) be routinely measured after COVID‐19? Comment on the article by Stahl et al	24
Reply	24
Reply	24
Differences in IgG Sialylation Distinguish Asymptomatic From Symptomatic Antinuclear Antibody–Positive Individuals	24
Clinical Connections	24
Transforming Rheumatology Practice With Technology: Products, Processes, People, and Purpose	24
Genome‐Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim‐Chester Disease	24
Reply	24
Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease	23
Association of 18F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis	23
Mapping and Analysis of Protein and Gene Profile Identification of the Important Role of Transforming Growth Factor Beta in Synovial Invasion in Patients With Pigmented Villonodular Synovitis	23
Hand Swelling and Other Non–Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US	23
Increased risk of statin‐associated autoimmune myopathy among American Indians	23
Promotion of Joint Degeneration and Chondrocyte Metabolic Dysfunction by Excessive Growth Hormone in Mice	23
Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c + Dendritic Cell Dysregul	23
Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 Mice	23
Drugs induced Raynaud's phenomenon and underlying mechanism: a disproportionality analysis from the WHO pharmacovigilance database	22
Skeletal Muscle Composition, Power, and Mitochondrial Energetics in Older Men and Women With Knee Osteoarthritis	22
List of Reviewers	22
Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comor	22
Autoantigen peptide‐8‐arm PEG ‐Dyes ( APP ‐Dyes) specifically recognize antigen‐specific B cells a	22
Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al	22
Predictors of Rheumatic Immune‐Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer	22
Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis	22
Circulating interferon alpha protein measured with digital enzyme‐linked immunosorbent assay as a biomarker for modified Rodnan skin score progression in limited systemic sclerosis: comment on the art	22
Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma	21
Clinical Images: Erdheim‐Chester disease presenting with palpitations and spondylopathy	21
Cartilage Acidic Protein 1 in Plasma Associates With Prevalent Osteoarthritis and Predicts Future Risk as Well as Progression to Joint Replacements: Results From the UK Biobank Resource	21
Complement	21
Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis–Associated Interstitial Lung Disease	21
In This Issue	21
Issue Information	21
ADAM9 Promotes Glycolysis in Th17 Cells and Autoimmunity Through Activation of IGF ‐1 Signaling	21
Correspondence and comments on American College of Rheumatology and EULAR antiphospholipid syndrome classification criteria: comment on the article by Barbhaiya et al	21
Plasma Proteomic Profiles Predict Individual Future Osteoarthritis Risk	21
The effect of air pollution and genetic susceptibility on systemic lupus erythematosus: comment on the article by Xing et al	21
Reply	21
Weight Reduction and Target Serum Urate Level: A Longitudinal Study of Annual Medical Examination	21
Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response	21
Association of alcohol consumption with disease activity and health‐related quality of life in rheumatoid arthritis: comment on the article by Alfredsson et al	20
Phenotype Risk Score but Not Genetic Risk Score Aids in Identifying Individuals With Systemic Lupus Erythematosus in the Electronic Health Record	20
Reply	20
	20
Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides	20
Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities	20
	20
ChatGPT, et al…Artificial Intelligence, Authorship, and Medical Publishing	20
Journal Club	20
Clinical Connections	20
Risk of arrhythmia among new users of hydroxychloroquine: comment on the article by Hoque et al	20
Weighing the Cardiovascular Risks of Low‐Dose Glucocorticoids in Rheumatoid Arthritis From Real‐World Data	20
Clinical Connections	20
Reply	20
Should Low Serum Urate Be Exonerated? Untangling the Influence of Sarcopenia in Observational Studies	19
Clinical Connections	19
Serious Infections in Offspring Exposed to Tumour Necrosis Factor Inhibitors During Pregnancy: Comparison of Timing During Pregnancy and Placental Transfer Ability	19
Rheumatology Is Amazing	19
The Characteristics of Patients With COVID‐19–Associated Pediatric Vasculitis: An International, Multicenter Study	19
Gout and Excess Risk of Severe SARS–CoV‐2 Infection Among Vaccinated Individuals: A General Population Study	19
Risk of serious infection between belimumab and oral immunosuppressants for non‐renal systemic lupus erythematosus: comment on the article by Materne et al	19
Reply	19
A Genome‐Wide Association Study Meta‐Analysis of Alpha Angle Suggests Cam‐Type Morphology May Be a Specific Feature of Hip Osteoarthritis in Older Adults	19
Single‐Cell Profiling of Bone Marrow B Cells and Early B Cell Developmental Disorders Associated With Systemic Lupus Erythematosus	18
Refining the Interpretation of Drug Survival and Safety in VEXAS Syndrome: The Importance of Competing Risks and Exposure Time	18
Identification of Novel Loci Shared by Juvenile Idiopathic Arthritis Subtypes Through Integrative Genetic Analysis	18
Peripheral γδ T Cells Regulate Neutrophil Expansion and Recruitment in Experimental Psoriatic Arthritis	18
Genetic Architecture of Idiopathic Inflammatory Myopathies From Meta‐Analyses	18
Diversity and Epitope Spreading of Anti–RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement	18
The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids	18
A Randomized, Placebo‐Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings	18
Long‐Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor–Associated Periodic Syndrome: Results From a Phase III Trial	18
Expert Perspective: Hematologic Malignancies and Vasculitis	18
A Novel Human Interleukin‐23A Overexpressing Mouse Model of Systemic Lupus Erythematosus	18
Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are Included	18
Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial	17
Urinary Biomarkers Associated With Pathogenic Pathways Reflecting Histologic Findings in Lupus Nephritis	17
A diagnostic performance study of the 2023 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for patients with antiphospholipid syndrome from	17
Impaired Efferocytosis by Synovial Macrophages in Patients With Knee Osteoarthritis	17
Association of a Combination of Healthy Lifestyle Behaviors With Reduced Risk of Incident Systemic Lupus Erythematosus	17
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data	17
Predisposal of Interferon Regulatory Factor 1 Deficiency to Accumulate DNA Damage and Promote Osteoarthritis Development in Cartilage	17
Genetics of Childhood‐Onset Systemic Lupus Erythematosus	17
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis	17
Multimodal Single‐Cell Sequencing of B Cells in Primary Sjögren's Syndrome	17
A Multicenter, Prospective, Randomized, Parallel‐Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Pati	17